PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
May 1, 2026Vaccines2 citationsOpen Access

Vaccine-Preventable Disease Control in the WHO African Region After the COVID-19 Public Health Emergency of International Concern: Implications for Recovery, Resilience, and System Transformation

CWCharles S. WiysongeCWCharles S. WiysongeAAAbdu A. Adamu

Key Points

  • The aim is to evaluate the recovery of immunization systems in the WHO African Region after the COVID-19 emergency and identify implications for future strategies.
  • Thematically analyzed publicly available data from WHO and other sources.
  • Utilized a systems-oriented framework covering various aspects of immunization systems.
  • Focus on immunization coverage, equity, vaccine introductions, and surveillance.
  • Regional vaccine coverage was restored to pre-pandemic levels by 2024, but targets remain unmet.
  • 6.7 million zero-dose children identified in the 2024 cohort, indicating an increase from 2019 figures.
  • Progress has plateaued despite initiatives, highlighting ongoing structural constraints and persistent immunity gaps.

Abstract

Background: The end of the COVID-19 public health emergency of international concern (PHEIC) in May 2023 marked a transition from disruption to recovery and rebuilding of health systems. The WHO African Region entered this period with declining routine immunization coverage, widening inequities, and fragile surveillance systems. We conducted a critical narrative synthesis of post-PHEIC recovery and the transformation of immunization systems in the region from 2023 to 2025. Methods: We thematically analyzed publicly available data from the WHO and other sources using a systems-oriented framework covering immunization coverage, equity, vaccine introductions, disease control, governance, financing, and data systems. Results: Regional coverage for most antigens was restored to 2019 pre-pandemic levels by 2024, e.g., three doses of diphtheria-tetanus-pertussis-containing vaccines at 76%. However, progress remains insufficient to meet the Immunization Agenda 2030 (IA2030) target of 90% coverage. In addition, there were 6.7 million zero-dose children in the 2024 birth cohort (6.3% higher than the 6.3 million in 2019), concentrated in a few countries. The IA2030 target is a 50% reduction in the number of zero-dose children by 2030, compared to 2019. Recovery initiatives have restored services, while accelerated introductions (e.g., malaria vaccines introduced in 20 new countries in 2024–2025) signal renewed system momentum. Yet, progress has plateaued at pre-pandemic levels, reflecting structural constraints rather than sustained transformation. Concurrently, recurrent outbreaks of measles, yellow fever, and other vaccine-preventable diseases highlight persistent immunity gaps and surveillance limitations. Structural constraints (including financing fragility, subnational inequities, and system fragmentation) continue to limit sustained progress. Conclusion: This study offers important insights that can inform immunization policymaking in the WHO African Region and beyond. Current post-PHEIC trends reflect recovery without transformation. Achieving IA2030 targets will require a shift from broad coverage expansion to precision delivery approaches that prioritize zero-dose and underserved populations. Immunization must be positioned as a central pillar of primary health care and health security systems.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Wiysonge et al. (2026) studied this question.

synapsesocial.com/papers/69f442fc967e944ac5566558https://doi.org/10.3390/vaccines14050386
Ask AI
Helpful
Bookmark
Share
View Full Paper